好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cryptococcal Meningitis and Suspected Small Vessel Vasculitis in an Immunocompetent Patient: A Case Report
Infectious Disease
P8 - Poster Session 8 (11:45 AM-12:45 PM)
4-005

To summarize a case of cryptococcal meningitis with suspected, delayed small vessel vasculitis in an immunocompetent patient.

Cryptococcus neoformans infections are rare among immunocompetent individuals; however, roughly 220,000 cases are reported yearly, affecting patients with HIV/AIDS, organ transplant, and chronic steroid use, among other conditions. We present a healthy 23-year-old intravenous drug user seronegative for the human immunodeficiency virus with cryptococcal meningitis and findings consistent with cryptococcal small-vessel vasculitis. The patient presented with a 1-week history of headache, nausea, vomiting, nuchal rigidity, and altered mental status. The patient had 3 serial lumbar punctures, each 4 to 5 days apart, with elevated opening pressures between 37-55 cm H2O and the presence of cryptococcal antigen. Initial magnetic resonance imaging showed an acute infarction of the splenium of the corpus callosum. The patient was treated with 6 weeks of amphotericin B and flucytosine. Despite antifungal treatment, the patient experienced a neurologic decline on day 37 with repeat magnetic resonance imaging revealing accumulation of new infarcts in the bilateral basal ganglia, head of the caudate, and bilateral cerebellar hemispheres. Conventional angiogram revealed no large-vessel vasculopathy and was consistent with cryptococcal small-vessel vasculitis. The patient was treated with intravenous dexamethasone 10mg once, followed by 4mg every 6 hours with a taper over 2 weeks. There was no further neurological worsening over the subsequent 3 weeks.

NA
NA

This case suggests that in appropriately treated cryptococcal meningitis, a delayed para-infectious process might be responsible for cerebral infarction. Infarcts secondary to cryptococcal vasculitis are most commonly seen in the basal ganglia. In these patients for whom antifungal therapy has already been optimized, the addition of corticosteroids may be useful in suppressing an inflammatory response.

Authors/Disclosures
Richa Thakkar, DO
PRESENTER
Dr. Thakkar has nothing to disclose.
Kyle R. Marden, MD (Northwestern Medicine) Dr. Marden has nothing to disclose.
No disclosure on file
No disclosure on file
James E. Siegler III, MD (University of Chicago) Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.